Spruce Biosciences (SPRBD) News Today $8.20 -0.30 (-3.53%) As of 08/22/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsBuy This Stock Why Is Spruce Biosciences Down Today?Toggle Visibility of Why Is Spruce Biosciences Down Today?Spruce Biosciences, Inc. (SPRBD) shares declined today amid a flurry of mixed earnings‐per‐share (EPS) forecast updates from Leerink Partnrs. While the firm lifted several key estimates for late-2025 and beyond, it also trimmed its near-term outlook for Q3 2025. Below is a breakdown of the analyst activity and other noteworthy items for investors. Positive Sentiment: Leerink Partnrs raised its Q4 2025 EPS estimate to ($2.55) from a prior ($5.26). Free Report Positive Sentiment: The same team lifted its FY 2025 EPS forecast to ($2.83) from ($51.13). Free Report Positive Sentiment: FY 2026 EPS estimate was boosted to ($11.31) from ($30.83). Free Report Neutral Sentiment: Leerink also released initial EPS projections for Q1–Q4 2026 (range: $2.65–$3.01 loss per share) and FY 2027 at ($10.52) EPS. Free Report Neutral Sentiment: Brokers have begun publishing Q1 earnings predictions for SPRBD. Brokers Offer Predictions for OTC:SPRBD Q1 Earnings Negative Sentiment: Leerink cut its Q3 2025 EPS forecast to ($15.56) from ($14.29), signaling a more challenging near-term revenue or expense outlook. Free Report Posted 1+ days agoAI Generated. May Contain Errors. SPRBD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q3 Earnings Forecast for OTC:SPRBD Issued By Leerink PartnrsAugust 23 at 2:36 AM | americanbankingnews.comBrokers Offer Predictions for OTC:SPRBD Q1 EarningsAugust 22 at 2:17 AM | americanbankingnews.com Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRBD and its competitors with MarketBeat's FREE daily newsletter. Email Address SPRBD Media Mentions By Week SPRBD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRBD News Sentiment▼0.610.69▲Average Medical News Sentiment SPRBD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRBD Articles This Week▼110▲SPRBD Articles Average Week Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:SPRBD) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access